Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Social Media Perceptions Among Young Adults With Cancer - Online Experiment 1 (SIYA MOS1)

4 novembre 2026 mis à jour par: UNC Lineberger Comprehensive Cancer Center

Young adults with cancer experience more loneliness than their non-cancer peers or older cancer survivors. Positive psychology interventions may increase social connectedness; however, evidence-based interventions should be tailored to young adults with cancer and designed for social media. This study conducted an online experiment with young adults with cancer (ages 22-39) to optimize intervention messages.

Aperçu de l'étude

Description détaillée

To examine how message types and personal stories influence reactions, the study used a mixed between-within online experiment. The researchers hypothesized that four message types (connected peer advocates, lonely peer advocates, cancer peers, and clinicians) would lead to greater perceived message effectiveness in encouraging positive in-person social interactions and stronger intended message reactions compared with control messages (H1). They also hypothesized that including a personal story (cancer-related or general) would improve perceived message effectiveness and intended message reactions (H2). Unintended message reactions were also explored.

Type d'étude

Interventionnel

Inscription (Réel)

505

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • North Carolina
      • Chapel Hill, North Carolina, États-Unis, 27599
        • University of North Carolina at Chapel Hill

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

22 ans à 39 ans (Adulte)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • Participants must be 22-39 years old at the time of the study
  • Participants must have received a cancer diagnosis at any point between ages 15-39
  • Participants must self-report low-to-moderate psychosocial quality of life (QOL), defined as an average rating of 4 or lower on the National Institutes of Health's (NIH's) validated 2-item Patient Reported Outcomes Measurement Information System (PROMIS) global mental health scale (two 5-point items)
  • Participants must use social media

Exclusion Criteria:

  • None

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Autre
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Aucun (étiquette ouverte)

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Connected advocate advice

Participants viewed five social media-based messages consisting of photographs of peers who are cancer advocates who have successfully created social connections and captions with advice for having more in person connections.

Participants were randomized to 1 of 5 message conditions.

Expérimental: Lonely advocate advice

Participants viewed five social media-based messages consisting of photographs of peers who are cancer advocates who are experiencing loneliness but still try to have social connections and captions with advice for having more in person connections.

Participants were randomized to 1 of 5 message conditions.

Expérimental: Peer-to-peer sharing

Participants viewed five social media-based messages consisting of peer-to-peer sharing about connecting with others and captions with advice for having more in person connections.

Participants were randomized to 1 of 5 message conditions

Expérimental: Clinician advice

Participants viewed five social media-based messages consisting of photographs of clinicians and captions with advice for having more in person connections.

Participants were randomized to 1 of 5 message conditions.

Expérimental: Control messages

Participants were randomized to 1 of 5 message conditions.

Participants were randomized to 1 of 5 message conditions.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Perceived Message Effectiveness (Single-Item Self-Report, 5-Point Scale)
Délai: Baseline, Up to 1 hour

After viewing each of 5 social media posts, participants answered one item: "How much does this post make you want to connect in person with people you barely know more often?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater perceived message effectiveness. Ratings were compared across experimental conditions and message types.

Baseline, Up to 1 hour

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Positive Affect (Single-Item Self-Report, 5-Point Scale)
Délai: Baseline, Up to 1 hour

After viewing each of 5 social media posts, participants answered one item: "How good does viewing this post make you feel?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater positive affect. Ratings were compared across experimental conditions and message types.

Baseline, Up to 1 hour
Perceived Social Presence (Single Item Adapted From Lazard et al., 2020; 5-Point Scale)
Délai: Baseline, Up to 1 hour

After viewing each of 5 social media posts, participants answered one item: "When viewing this post, how much do you feel as if someone is talking to you?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater perceived social presence. Ratings were compared across experimental conditions and message types.

Baseline, Up to 1 hour
Message Relevance (Single Item Adapted From Jensen et al., 2024; 5-Point Scale)
Délai: Baseline, Up to 1 hour

After viewing each of 5 social media posts, participants answered one item: "How relevant is this post to you?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater perceived relevance. Ratings were compared across experimental conditions and message types.

Baseline, Up to 1 hour
Attention (Single Item Adapted From Sutfin et al., 2019; 5-Point Scale)
Délai: Baseline, Up to 1 hour

After viewing each of 5 social media posts, participants answered one item: "How much does this post grab your attention?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater attention. Ratings were compared across experimental conditions and message types.

Baseline, Up to 1 hour
Perceived Authenticity (Single-Item Self-Report, 5-Point Scale)
Délai: Baseline, Up to 1 hour

After viewing each of 5 social media posts, participants answered one item: "How much do you think this post shares a real perspective?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater perceived authenticity. Ratings were compared across experimental conditions and message type.

Baseline, Up to 1 hour

Autres mesures de résultats

Mesure des résultats
Description de la mesure
Délai
Negative Affect, Unintended Reaction (Single-Item Self-Report, 5-Point Scale)
Délai: Baseline, Up to 1 hour

After viewing each of 5 social media posts, participants answered one item: "How bad does viewing this post make you feel?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater negative affect (a less favorable reaction). Ratings were compared across experimental conditions and message types.

Baseline, Up to 1 hour
Reactance, Unintended Reaction (Single Item Adapted From Hall et al., 2017; 5-Point Scale)
Délai: Baseline, Up to 1 hour

After viewing each of 5 social media posts, participants answered one item: "How much does this post annoy you?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater reactance (a less favorable reaction). Ratings were compared across experimental conditions and message types.

Baseline, Up to 1 hour

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Allison J Lazard, PhD, UNC Lineberger Comprehensive Cancer Center

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

27 mai 2025

Achèvement primaire (Réel)

23 juillet 2025

Achèvement de l'étude (Réel)

23 juillet 2025

Dates d'inscription aux études

Première soumission

27 octobre 2026

Première soumission répondant aux critères de contrôle qualité

4 novembre 2026

Première publication (Réel)

10 novembre 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

10 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

4 novembre 2026

Dernière vérification

1 novembre 2026

Plus d'information

Termes liés à cette étude

Termes MeSH pertinents supplémentaires

Autres numéros d'identification d'étude

  • SIYA MOS1 Online Experiment 1
  • R01CA276176 (Subvention/contrat des NIH des États-Unis)

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner